Recently, the Food and Drug Monitoring Agency (BPOM) has issued an emergency use authorization (EUA) for five types of Covid-19 booster shots to improve the protection people have from the first two doses previously received. The five vaccines are CoronaVac (Sinovac), Pfizer, AstraZeneca, Moderna, and Zifivax.
The EUA would allow the implementation of homologous and heterologous booster vaccine programs. The homologous vaccination uses the same vaccine type as the primary series vaccine, while the heterologous vaccination uses a different vaccine type from the initial vaccine.
The first three vaccines comprising CoronaVac, Pfizer, and AstraZeneca will be used for homologous vaccination. The other vaccine types will be used for heterologous vaccination.
“PT Bio Farma’s Coronavac vaccine is used for homologous vaccination which will be given one dose to people aged 18 years after receiving the complete primary vaccine in six months,” BPOM head Penny Lukito told a press conference on Monday, Jan. 10.
She also said that the Pfizer vaccine will be used for homologous vaccination.
Besides the five vaccines, BPOM is currently conducting clinical trials for other Covid-19 vaccines that will also be used for the booster jabs. “We hope that BPOM will issue the authorization for emergency use in a few days.”
(Writer: Dian Erika Nugraheny | Editors: Krisiandi, Dani Prabowo)https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.